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Many RNA tumor viruses preferentially induce neoplasms of hematologic or 
lymphoid tissue in susceptible animals. According to their oncogenic potential, 
these retroviruses are divisible into two groups, the acute leukemia viruses and 
the slow or chronic leukemia viruses. The acute viruses, such as Abelson murine 
leukemia virus (AbLV), 1 cause rapid onset of neoplastic disease (2-4 wk) follow- 
ing infection in vivo and can transform appropriate target cells in tissue culture 
(1,  2).  Inoculation  with  slow  leukemia viruses,  which  include  the  avian  and 
murine leukemia viruses (ALV and  MuLV),  results  in  neoplasia  only after a 
prolonged latent period of 3-12  months. They have not been found to cause 
morphological transformation of tissue culture cells (3, 4). 
The mechanism(s) of oncogenesis by these viruses is not yet understood. The 
transforming activity of the acute viruses  has been attributed  to  a  particular 
genomic region termed the onc gene. Onc sequences do not encode viral structural 
proteins, but rather are thought to have been acquired by recombination from 
cellular DNA at the expense of replicativ¢ genes. As a result, these viruses are 
uniformly replication defective (1, 5, 6). The translation product of such an onc 
gene in transformed cells appears as a "fusion" protein, consisting of the putative 
transforming protein colinear with viral peptides.  In the example of AbLV, a 
120,000-dalton protein (p 120) containing portions of Mo-MuLV p 15, p 12, and 
p30  gag polypeptides covalently linked to a  highly phosphorylated cell-derived 
fragment  is  thought responsible  for  transformation  (7).  The  slow  leukemia 
viruses, in contrast, contain no readily definable transforming genes. Neel et al. 
(8) and Payne et al. (9) have acquired evidence suggesting that the majority of 
bursal lymphomas induced in chickens by the slow ALV result from activation 
of a  cellular oncogene by vicinal integration of viral promoter elements. How- 
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ever,  oncogenesis by promoter  insertion  has not been documented for MuLV 
lymphomagenesis. 
Recently Manteuil-Brutlag et al. (10) described an analysis of radiation leuke- 
mia virus (RadLV) RNA. Their results indicate that leukemogenic preparations 
of RadLV contain a presumed defective 5.6-kb RNA along with full-length 8.0- 
kb molecules.  Closely related,  but nonleukemogenic  BL/Ka (B) virus has only 
the 8.0-kb species. When translated in vitro, the 5.6-kb RNA produced polypep- 
tides  of  100  kdaltons,  36  kdaltons,  and  30  kdaltons,  which  expressed  gag 
antigenic determinants.  By analogy to the acute defective leukemia viruses, these 
investigators propose an oncogenic function for the products of the 5.6-kb RNA. 
Thus  the  leukemogenic agent  may be a  replication-defective agent  associated 
with helper viruses and  not the complete virus, as suggested by Decleve et al. 
(11) and Lieberman et al. (12). 
The present study reports analysis of a gag-associated 36,000 molecular weight 
protein  (p36)  expressed  by  thymic  lymphoma  cell  lines  induced  by  RadLV. 
Evidence differentiating p36 from gag intermediates and supporting its associa- 
tion  with  cells transformed  by RadLV  is  presented.  The  possible origins  and 
involvement of this protein in RadLV leukemogenesis are discussed. 
Materials and Methods 
Virus  and  Antisera.  RadLV  was  prepared  as  20%  cell-free  extracts  of thymomas 
induced by intrathymic injection  of similarly in vivo passaged  RadLV. It was originally 
derived from radiation-induced murine lymphomas by Lieberman and Kaplan (13). Goat 
anti-viral  antisera  were kindly  provided by Dr. J. Cole,  National  Cancer Institute,  Be- 
thesda,  MD.  These  included  anti-Tween-ether-disrupted  AKR  MuLV  (4S-97),  anti- 
Tween-ether-disrupted  BALB:virus-2  (5S-91), anti-Rauscher virus (R-MuLV) p30 (6S- 
492), anti-R-MuLV p12 (5S-37), anti-AKR-MuLV  pl 0 (5S-465), anti-R-MuLV  pl 5 (78S- 
30), and R-MuLV gp70 (5S-167); also provided was fluorescein isothiocyanate  (FITC)- 
conjugated  goat  anti-mouse  immunoglobulin  for  indirect  immunofluorescence assays. 
Monoclonal anti-pl 5(E)  ~7~ was a gift of Dr. Bruce Chesebro (14). 
Cell Lines 
The AQR-V, B10.G-V,  B10.S-V, and B6-V1 lines were established  into tissue culture 
from  RadLV-induced  thymomas  from  mice  of C57BL  lineage,  with  the  line  name 
reflecting mouse strain  of origin.  Likewise, AQR-X1 and B6-X1 were established  from 
radiation-induced thymomas. The RL-12 and L691-6 cell lines were originally adapted to 
tissue culture elsewhere from radiation lymphomas of C57BL/Ka and C57L mice, respec- 
tively (15,  16). The III6A clone of Sc-1 cells, obtained from Dr. T.  Pincus (Vanderbilt 
University), was originally derived from a feral mouse embryo by Hartley and Rowe (17), 
and lacks Fv-I type restriction of ecotropic MuLV. The mink lung cell line CCL64 was a 
generous gift of Dr. A. Mayer (New York University Medical center).  Cells were routinely 
maintained  in  Dulbecco's modified Eagle's  medium (DME) with  10%  fetal  calf serum 
(FCS) supplemented with antibiotics (complete DME), except RL-12, which grew in RPMI- 
1640 with  10% FCS and antibiotics. 
Infection Procedures 
Assay.  The methods used for infecting  cells with MuLV were minor modifications of 
those described (18,  19). For monolayer cells, 2 X l0 B  were seeded into 25-cm 2 T-flasks 
(Corning Glass Works)  in  5 ml of complete DME; the following  day, the medium was 
removed and the cells treated with 25 t~g/ml of diethylaminoethyl (DEAE)-dextran  (Sigma 
Chemical  Co., St. Louis, MO) in DME for 1 h at 37°C, after which the DEAE-dextran 
solution  was removed and 0.5 ml of AQR-V culture supernatant  sterilized  by filtering 272  IDENTIFICATION  OF A  GAG-RELATED PHOSPHOPROTEIN 
through a nitrocellulose membrane (0.45 #m, Miilipore Corp., Bedford, MA) and con- 
taining 4  ug/ml polybrene (Aldrich Chemical Co.,  Milwaukee, WI), was  added.  After 
incubation at 37°C for 2 h, the flasks were fed with 5 ml of complete DME, and passaged 
at confluency, approximately every 6-7 d. 
For suspension cells,  1 ×  105 cells in log phase were mixed in 24-well  Linbro cluster 
plates with an equal volume (0.2 ml) of filtered (0.45 ~m, Miilipore) culture supernatant 
containing 4 #g/ml polybrene. After a 2 h adsorption in humidified 5% CO~ incubator at 
37 °C, 1 ml of medium was added. Medium was changed three times weekly. 
The number of virus-positive cells was determined at various intervals after infection 
using an indirect immunofluorescence procedure on fixed cells (18, 20). 
Radiolabeling and Cell Extraction 
Suspension cells were radiolabeled metabolically with [SH]ieucine as follows. Cells were 
washed 3x in cold sterile PBS. For 1-5 h steady-state or pulse-chase labeling periods, cells 
were resuspended at 25 x  106 cells per ml with DME minus leucine (or RPMI-1640 minus 
leucine for RL-12 cells) (Gibco Laboratories, Grand Island, NY) supplemented with 2% 
FCS,  1% penicillin/streptomycin, and  250 #Ci/ml of L-[3,4,5-SH(N)]-ieucine  (148-152 
Ci/mmol; New England Nuclear [NEN], Boston, MA). Cells were incubated in humidified 
5% COu at 37 °C with frequent mixing. For overnight labeling, cells were resuspended to 
1  ×  106/ml  in  DME  plus  one-tenth  the  normal  concentration of ieucine,  2%  FCS, 
penicillin/streptomycin, and  25  uCi/ml  [SH]leucine.  When  [sSS]methionine (1,300  Ci/ 
mmol; Amersham Corp., Arlington Heights, IL) was used, DME minus methionine (Gibco) 
was  substituted  in  the  procedure.  Monolayer cells were  labeled just  as  they reached 
confluency by washing 3×  with sterile PBS, then adding 0.8 ml of the above labeling 
medium. For incorporation of radioactive phosphate, cells were washed 3× in phosphate- 
free DME (Gibco), then resuspended to 25  x  106/ml  in phosphate-free DME with  2% 
FCS,  1% penicillin/streptomycin, and 300 #Ci/ml [3~P]-orthophosphoric acid (3,000 Ci/ 
mmol; NEN) for 4 h. 
Following labeling, cells  were washed  3x with  ice-cold PBS and disrupted in lysing 
buffer consisting of 0.5% NP-40/20 mM Tris-HC! (pH 7.5)/100 mM NaC1]2 mM EDTA/ 
2  mM phenylmethylsulfonyl fluoride (PMSF,  Sigma) on ice for 45  min  with  frequent 
vortexing. Lysates were clarified by centrifugation at 33,000 g and stored at -70°C until 
use. To determine incorporated trichloroacetic acid (TCA)-precipitable radioactivity, 1- 
#1 samples were added to 0.5 ml PBS containing 5% FCS and precipitated with 0.5 ml of 
20% TCA for 30 min on ice. Precipitates were collected by centrifugation for 10 min at 
11,000 g in a microfuge (Beckman Instruments, Spinco Div., Palo Alto, CA), redissolved 
in 100 #1 PBS, and added to 2 ml of Betaphase scintillation solution (WestChem Products, 
San Diego, CA).  Radioactivity was assayed using a  Beckman LS-250 liquid scintillation 
counter. 
Virus Purification 
Supernatant from 20 h labeled cells was clarified by centrifugation at 2,000 g at 4°C 
and spun through discontinuous 25-45% (wt/vol) gradients of sucrose in 50 mM Tris- 
HCI (pH 7.5)/100 mM NaCI/1  mM EDTA (TNE) at 26,000 rpm for 2 h in an SW-27 
rotor (Beckman). Material sedimenting at the interphase was diluted in TNE and layered 
onto 15 ml preformed 15-60% continuous sucrose gradients and spun for 17 h at 26,000 
rpm in an SW-27 rotor. Fractions of 0.8 ml were collected and refractive indices measured; 
fractions containing sucrose densities of 1.14 to 1.16 g/cm  s were pooled and pelleted at 
39,000 rpm in a type 40 rotor. Viral pellets were either resuspended in electrophoresis 
sample buffer (2%  NaDodSO4/80 mM Tris-HCl (pH 6.8)/10% glycerol/2 mM EDTA/ 
5 %/3-mercaptoethanol/0.001% bromophenol blue) or in lysing buffer for immunoprecip- 
itation analysis. 
Immunoprecipitation 
Aliquots of cellular lysates  containing  10-20 x  106 TCA-precipitable cpm were pre- 
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addition of 200 #1 of 10% formalin-fixed Staphylococcus aureus A (Cowan strain) (SAC; 
The Enzyme Center, Inc., Boston, MA) suspended in lysing buffer containing 1% bovine 
serum albumin  (BSA) for 60 min at 4°C.  The SAC was removed by centrifugation at 
1,000 g in a microfuge for 5  min, and the precleared supernatant was then incubated 
overnight at 4°C with 5-20 #1 of the appropriate antiserum or ascites fluid. The next 
morning,  200  ~1  of SAC  suspension  was  added  for 60  rain  at  4°C  and  pelleted by 
centrifugation at 2,000 g for 10 min. SAC pellets were washed 5x with 1% deoxycholate/ 
1% Triton X-100/0.1% SDS in TNE buffer, then resuspended in 80 #i of electrophoresis 
sample buffer. 
Gel Electrophoresis 
NaDodSO4/polyacrylamide gel electrophoresis was routinely run using the discontin- 
uous Tris-glycine system of Laemmli (21). Samples were treated to 100 °C for 5 rain, SAC 
removed by centrifugation, and eluted proteins electrophoresed on 23-cm gradient gels 
of 7.5-18% or 10-18% acrylamide (30:0.8, acrylamide to bisacrylamide; Bio-Rad Labo- 
ratories),  topped  with  2.5-cm  stacking  gels  of 4.5%  acrylamide,  for  20  h  at  130V. 
Molecular weight  marker proteins  (Bio-Rad,  Richmond,  CA)  were  coelectrophoresed 
included phosphorylase b (molecular weight 92,500), BSA (66,200), ovalbumin (45,000), 
carbonic anhydrase (30,000), soybean trypsin inhibitor (21,500), and lysozyme (14,400). 
Molecular weights were confirmed using 14C-labeled standard proteins (NEN). Gels were 
fixed and  stained  in  0.1%  Coomassie  Brilliant  Blue R  in  50%  TCA  for  30  min  and 
destained  in  several  changes  of 7%  glacial  acetic acid.  The  gels  were  processed  for 
fluorography by washing in cold running water for 15 min, soaking in 3-gel volumes of 
Autofluor (National Diagnostics Inc., Somerville, N  J) containing 1% glycerol for 60 rain 
at 20°C, and drying on Whatman 3MM paper under vacuum at 80°C. Dried gels were 
exposed to Kodak XAR-5 film at -70°C and developed using an automated Kodak X- 
OMAT processor. 
Tryptic Peptide Analysis 
Radiolabeled proteins to be fingerprinted using the general method of Elder (22), were 
resolved by NaDodSO4/polyacrylamide gel electrophoresis of immunoprecipitates. Bands 
were cut from fixed and dried gels using a razor blade with the fluorogram as a template 
guide. Gel slices were placed in 12 × 75 mm tubes and washed overnight in three changes 
of 2 ml dH~O at 4°C to remove water-soluble fluors and glycerol, then in 2 ml 0.05 M 
NH4HCO3 buffer (pH 8.0) for 4-6 h at 4°C. Supernatant was then completely aspirated 
and 0.5 ml of 0.05 M N H4HCO3 (pH 8.0) containing 50 #g/ml of tosylsulfonyiphenylalanyi 
chloromethyl ketone (TPCK)-treated trypsin (Worthington Biochemical Corp., Freehold, 
NJ) was added. Tubes were covered and incubated overnight at 37 °C in a shaking water 
bath, after which supernatants were removed and lyophilized. Samples were dissolved in 
10 ~1 of Buffer I (acetic acid-formic acid-water,  15:5:80) and carefully spotted onto 10 
×  10  cm  cellulose-coated thin  layer chromatograph  (TLC)  plates  (EM  Laboratories, 
Elmsford, NY).  The samples were then electrophoresed using Buffer I  at 500 mV for 
-20 min on a water-cooled Multiphor 2117 apparatus (LKB Instruments, Inc., Rockville, 
MD). To monitor consistent electrophoresis, a mixture of 2% Orange G (wt/vol) and 1% 
acid-fuchsia (wt/vol) in Buffer I  was  spotted at the opposite end from the sample and 
migrated as an internal control. The plates were dried and peptides chromatographed in 
the second dimension using butanol-pyridine-acetic acid-water, 32.5:25:5:20. The plates 
were again dried, then dipped in  20%  2,5-diphenyloxazole (PPO) in acetone, redried, 
and exposed to Kodak XAR-5 film at -70°C and developed as above. 
Phosphoamino Acid Analysis 
To determine sites of protein  phosphorylation, amino acid analysis  was  performed 
essentially according to the  method of Beemon and  Hunter (23),  with  modifications. 
Immunoprecipitated proteins labeled in vivo with ~P-orthophosphate were separated by 
SDS-polyacryJamide gel electrophoresis and radioactive bands of interests cut from dried, 
unfixed, unstained gels. Slices were rehydrated with 0.5 M NH4CO~ (pH 8.0)/0.1% SDS 274  IDENTIFICATION  OF  A GAG-RELATED PHOSPHOPROTEIN 
(2 ml per 100 mm  2 of gel) and 2-mercaptoethanoi added to 5% (elution buffer). This was 
heated to 100 °C for 5 rain and proteins eluted overnight at 37 °C with constant shaking. 
The  following day,  solution was  removed from gel  fragments by centrifugation in a 
microfuge (Beckman) for 15 min, gel fragments washed with 1/2 the original volume of 
fresh buffer, supernatants pooled and passed through a  0.45-t~m Swinnex (Millipore) 
filter. To the filtrate 75 ug of bovine gamma globulin (Sigma) was added, and the solution 
was made 20%  with trichloroacetic acid. After incubation on ice  for 4 h, protein was 
pelleted by centrifugation at 10,000 rpm for 15 min. Dried precipitate was washed with 
cold (-10°C) absolute ethanol and ethanol/ether (1:1).  The resultant pellet was dried 
under vacuum, then hydrolyzed for 3.5 h in 100 t~l 6 N HCI with 20 #1 of 1% phenol in 
evacuated glass vials at 110 ° C. Following hydrolysis, HC1 was evaporated under vacuum 
and the hydrolysate redissolved in 5 ~1 of electrophoresis buffer (acetic acid, formic acid, 
water; 78:25:897)  containing 1 mg/ml each of phosphoserine, phosphothreonine, and 
phosphotyrosine markers (Sigma). This solution was spotted onto glass TLC plates (10 X 
10 cm) and e[ectrophoresed in the first dimension for 45 min at I kV. Plates were then 
chromatographed in the second dimension using isobutyric acid, 0.5  M NH4OH (5:3). 
Finished plates were dried and markers visualized  with 1% ninhydrin in acetone. Radio- 
actively labeled amino acids were detected by exposure to Kodak XAR-5 film at -70°C 
and developed as above. 
In Vitro Protein Kinase Assay 
Protein kinase activity was tested essentially by the method of Witte et al.  (24).  For 
each assay,  1 x  106 cells were extracted and clarified as above, then immunoprecipitated 
with appropriate antisera. An AbLV lymphoma line, 18-81, generously provided by Dr. 
N.  Rosenberg (Tufts  University Medical  Center),  was  used as a  positive  control and 
immunoprecipitated with anti-pl 2. Immune complexes were pelleted with SAC, washed 
4x with 0.5%  NP40/20  mM Tris-HCl (pH  8.0),  then resuspended in 50 ~1 of 20 mM 
Tris-HCl (pH 8.0)/10 mM MnCI2 containing 2.5 #Ci [~-~2P]-ATP (2900 Ci/mmol, NEN) 
for  10  min at  30°C,  washed, eluted with 85 #1  of electrophoresis sample buffer, and 
analyzed by gel electrophoresis as described above. 
Results 
Identification  of a Novel gag-Related  Protein  p36  in RadLV-induced Lymphoma 
Cell Lines.  In order to characterize the virally encoded polypeptides expressed 
by a  RadLV-induced thymic lymphoma, the AQR-V cell line was metabolically 
labeled with [3H]leucine, detergent lysed, and immunoprecipitated using antisera 
prepared  against  MuLV  proteins.  The  immunoprecipitates  were  analyzed by 
NaDodSO4/polyacrylamide  gel  electrophoresis  (Fig.  1A).  Normal  goat  serum 
(lane  1)  precipitated  no  detectable  radiolabeled  proteins  from  these  extracts; 
antisera prepared against disrupted ecotropic AKR virus (anti-AKR-MuLV) or 
xenotropic BALB:virus-2 (anti-BV2),  which react with virtually all of the viral 
structural proteins, precipitated several distinct bands (lanes 2 and 6) correspond- 
ing to major env and gag gene products.  Readily visualized are the env-coded 
Pr80 env and  Prl5(E),  which are  both  precipitable  by anti-pl5(E)  (lane  7)  and 
anti-Rauscher gp70 (not shown). By use of specific antisera, various gag-related 
molecules were identified. Anti-p30 (lane 3), anti-12 (lane 4), and anti-pl 5 (lane 
5)  all  precipitated  their  respective  mature  structural  products  along  with  the 
polyprotein precursor  Pr65 g~g and a  94,000-molecular  weight band that likely 
corresponds to the glycosylated cell surface polyprotein, gp94 gag. 
In addition to these commonly recognized viral proteins and precursor mole- 
cules  that  have  been  defined for a  variety of MuLV-infected cells  (25-27),  a 
major polypeptide of 36,000 molecular weight (p36) was present in anti-gag (Fig. BACH AND  MERUELO  275 
FIGURE  1.  Identification  of p36 in a RadLV-induced  lymphoma  cell line. (A) Immunoprecip- 
itates of 4-h [SH]leucine-labeled  AQR-V cell extracts were analyzed by NaDodSO4/polyacryl- 
amide gel electrophoresis  and visualized  by fluorography. Antisera used include normal goat 
serum (lane 1), goat anti-AKR MuLV (lane 2), goat anti-p30 (lane 3), goat anti-pl2 (lane 4), 
goat anti-pl5 (lane 5), goat anti-BV2 (lane 6), and monoclonal anti-plS(E) ascites (lane 7). (B) 
Virus purified from 20-h [SH]leucine-labeled  AQR-V culture supernatant was immunoprecip- 
itated with goat anti-AKR/MuLV (lane 2) or electrophoresed intact (lane 1). Labeled super- 
natant cleared of virus was also immunoprecipitated with goat anti-AKR-MuLV  (lane 3). The 
position of molecular weight standards is indicated, as are the identified viral proteins. 
1 A, lanes 3-5) immunoprecipitates, but absent from anti-env analyses (Fig.  1  A, 
lane  7)  for  anti  pl5E;  similar  results  were  obtained  when  several  anti-gp70 
reagents were used, data not shown) of AQR-V cellular extracts. Anti-p30 (lane 
3), anti-p 12 (lane 4), anti-p 15 (lane 5), and anti-p 10 (not shown) precipitate p36 
in different amounts, which may reflect antibody titer or avidity differences. As 
observed by others (28), the heteroantisera reactive with p 10, p 12, and p 15 may 
be  contaminated  with  low  levels  of antibody  to  p30,  therefore,  the  precise 
antigenic determinants present on p36 are ambiguous. However, the observation 
that anti-pl2  (lane  4)precipitates  larger amounts of p36  than of p30  suggests 
that  its  reactivity with  p36  is  not  due  solely to  these  contaminating anti-p30 
antibodies.  It  may  indicate  that  the  anti-gag  activity  seen  results  from  p12 
sequences present in p36. 276  IDENTIFICATION  OF  A GAG-RELATED PHOSPHOPROTEIN 
p36 Is Not Incorporated  into Virions.  It has been reported that RadLV prepa- 
rations may contain mixtures of viruses differing in host range and tissue tropism 
(29). To determine whether p36 was the product of a selected component among 
these  viruses  that  could  be  passaged  from  AQR-V  supernatant,  culture  fluid 
from the  cell line was  inoculated onto mouse Sc-1,  mink CCL64,  RL-12,  and 
L691-6 cells. The latter two lines are non-producer radiation-induced lymphomas 
that are  susceptible  to  MuLV  infection, and  reported  to  allow  replication  of 
thymotropic virus (19). The infected cultures were followed for the onset of viral 
expression by an indirect immunofluorescence assay using anti-MuLV antibody; 
after  5-8  passages  all  cultures  became  80-100%  viral  antigen  positive.  The 
cultures were then metabolically labeled, extracted, and analyzed as before (Fig. 
2) to test for production of p36.  It was found that neither the infected Sc-1  cells, 
replicating ecotropic  virus(es),  nor  the  infected CCL64  cells replicating xeno- 
tropic virus synthesized detectable p36 (Fig. 2A, lanes 1 and 2, respectively). By 
contrast, it was quite easy to immunoprecipitate viral structural molecules from 
these infected cell lines (data not shown). 
FIGURE 2.  p36 absence from cells infected with passaged AQR-V viruses. All cells were 
labeled for 4 h with [SH]leucine (A and B) or [sSSlmethionine (C), extracted, and equal amounts 
of TCA-precipitable radioactivity used for immunoprecipitation  analysis.  AQR-V is included 
for comparison.  (A) Goat anti-BV2 immunoprecipitate  of  infected CCL64  cells (lane 1), infected 
Sc-I cells (lane 2), and AQR-V (lane 3). (B) Goat anti-AKR MuLV (lanes 1-3) and goat anti- 
p l 2 (lanes 4-6) were used to precipitate AQR-V (lanes t and 4), uninfected RL-12 cells  (lanes 
2 and 5), and RL-12 cells infected with AQR-V supernatant virus (lanes 3 and 6). (C) Analysis 
of [sSS]methionine-labeled cells; normal goat serum (lane 7), goat anti-AKR MuLV (lanes 1- 
3) and goat anti-pl2 (lanes 4-6) were used to precipitate AQR-V (lanes 1 and 6), uninfected 
L691-6 cells (lanes 2 and 5), and L691-6 infected with AQR-V supernatant virus (lanes 3 and 
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The RL-12 and L691-6 cells also were found to replicate virus passaged from 
AQR-V supernatant.  Fig.  2, B and C show analyses of their cellular lysates for 
presence of p36. Extracts of uninfected RL-12 cells labeled with [SH]leucine and 
immunoprecipitated with anti-viral antibodies (Fig. 2B, lanes 2 and 5) show no 
detectable synthesis of viral  proteins.  Following infection with AQR-V  super- 
natant, the cells synthesize Pr65 g~s and p30, which are precipitated with either 
anti-AKR MuLV (lane 3) or anti-pl2 (lane 6). However, no p36 band is visible 
in these precipitates.  Equal amounts of TCA-precipitable radioactivity of [SH]- 
leucine-labeled AQR-V cellular extract  were also immunoprecipitated and co- 
electrophoresed  for  comparison  (lanes  1  and  4).  The  levels  of env and  p30 
proteins expressed by infected RL-12 cells is proportionally lower than in AQR- 
V cells over this labeling period, although the radioactivity in the Pr65 og bands 
is comparable. 
A similar analysis of [aSS]methionine-labeled L691-6 cell extracts is presented 
in Fig. 2 C. The precipitation using normal goat serum (lane 7) demonstrates the 
increased  background of nonspecific bands  detected  using 35S-labeled lysates. 
Uninfected L691-6 cells precipitated with anti-AKR MuLV or anti-pl 2 show no 
evidence of gag protein synthesis. But L691-6 infected with AQR-V supernatant, 
synthesize amounts of Pr65 g~g and p30 (lanes 3  and 4) comparable to AQR-V 
cells (lanes 1 and 6).  Nevertheless, p36 is not detectable in extracts of infected 
L691-6 precipitated with anti-AKR MuLV or anti-pl 2 (lanes 3 and 4). 
These  findings were  reproduced  using infectious virus derived  from other 
RadLV-induced lymphoma cells that produced p36 (see Table I). Recipient cells 
infected with virus from the B6-VI and B10.S-V lines and from in vivo primary 
RadLV  iymphomas  were  found  to  produce  easily  precipitable  env  and  gag 
proteins, but no p36 was detectable in anti-virus immunoprecipitates (data not 
shown). 
Since p36 was not detected after passage of AQR-V viruses in other cells, we 
checked AQR-V  supernatant  (which contains abundant amounts of infectious 
TABLE  I 
MuL V-Related Proteins Identified in L  ymphoma  Cell Line Extracts* 
Cell line 
Env-related  Gag-related 
gp70  pl5(E)  p30  p36 
RadLV-ind-uced: 
AQR-V  +  +  + 
B 10.G-V  +~  +  - 
B10.S-V  +  +  + 
B6-VI  +  +  + 
Radiation-induced: 
RL-12  +  _+  - 
L691-6  4-  4-  - 
AQR-X1  +  +  + 
B6-X1  +  +  + 
+ 
+ 
+ 
+ 
B 
B 
* Determined  by  gel  electrophoresis of specific immunoprecipitates  of 
[SH]leucine-labeled cell extracts. 
~: 4- indicates presence of very low quantities of protein as visualized on 
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viruses) directly for p36 activity. To test if p36 were incorporated into virions 
or secreted into culture medium, virus banding at 1.14-1.16 g/cm  s was purified 
from 24-h radiolabeled AQR-V supernatant. The virus was pelleted, extracted, 
and immunoprecipitated as above. No p36 was detectable in the virion prepara- 
tions precipitated with anti-AKR-MuLV  (Fig.  1 B, lane 2), although several of 
the mature viral polypeptides are readily apparent. Aliquots of culture superna- 
tant  from  which  virus  had  been  pelleted  were  also  immunoprecipitated with 
anti-AKR-MuLV  (lane 3).  The supernatant contained p30 and gp70, perhaps 
from lysed virions, but no p36 was found. These findings strongly suggest that 
p36 is either encoded by a defective viral genome (i.e., no replication capacity) 
or by cellular sequences which contain fused viral information (i.e., gag coded). 
p36 Independence  from gag Gene Products Synthesis Suggests it Might Be the Product 
of Fused Viral gag and Cellular Sequences.  The RadLV-induced B10.G-V  lym- 
phoma line appears unique in that it produces relatively large amounts of p36 in 
the absence of detectable p30 or Pr65 g~s (Fig. 3A, lanes  1 and 2). This lack of 
p30  synthesis  allowed  us  to  establish  the  independence  of  p36  biosynthesis 
from that of other gag-related proteins. B10.G-V cells were analyzed in a pulse- 
chase labeling experiment and immunoprecipitated with anti-AKR-MuLV (Fig. 
3B).  Significant amounts of p36 have been synthesized after the 20-min pulse 
period, while no Pr65 gag or p30 bands are apparent. The quantity of p36 peaks 
at ~30 rain of chase, after which there is a gradual decline. The kinetics of p36 
synthesis in B10.G-V  cells are not substantially different from the p36 kinetics 
in a  cell line such as AQR-V, which produces large quantities of viruses. Thus, 
in AQR-V cells most p36 is present after the initial 20-min pulse, along with a 
prominent Pr65 g~g band  (Fig.  3C).  As radioactivity  is  chased from Pr65 s~g, it 
does not appear to end up in p36, which also gradually decreases over the chase 
period.  However,  radioactivity  in  p30  increases  over  the  first  hour  of chase, 
consistent with its derivation from cleavage of Pr65 gag. 
To confirm directly that p36 is not an intermediate between Pr65 gag and p30, 
the radiolabeled proteins were purified by immunoprecipitation and NaDodSO4/ 
polyacrylamide  gel  electrophoresis,  and  subjeced  to  two-dimensional  tryptic 
peptide mapping (Fig. 4). Several p36 peptides differ from the p30 and Pr65 g~g 
peptides, emphasizing the fact that novel, cellular sequences are probably part 
of the p36 molecules. 
p36 Is Phosphorylated In  Vivo, but Does Not Express Detectable Protein Kinase 
Activity.  The fact that p36  appears  to  be  derived from fused gag (viral) and 
cellular genetic information and does not appear to be encoded by a replication 
competent virus, makes this protein homologous in many respects with several 
viral  oncogene  proteins  described  in  other  systems.  Many  of these  proteins, 
exemplified by  AbLV  p120,  are  phosphorylated and/or  have  protein  kinase 
activity (24, 26, 30). Therefore, we wished to examine p36 with respect to these 
two parameters.  The  B10.G-V  cell  line  was  metabolically  labeled  with  [S2p]_ 
orthophosphate,  and  cellular  extracts  subjected  to  immunoprecipitation  and 
NaDodSO4/polyacrylamide  gel  electrophoresis.  Fig.  3A  shows  the  results  of 
immune precipitations using normal serum (lane 3) or anti-AKR MuLV (lane 4). 
The p36  protein  is  the  most prominently labeled  phosphoprotein specifically 
precipitated  from the  B10.G-V  extract  with anti-viral  antisera.  Similar results BACH AND  MERUELO  279 
FIGURE 3.  Expression  of p36 in a nonproducer RadLV-induced lymphoma line. (A) B10.G- 
V cells were labeled 4 h with [3H]leucine  (lanes 1 and 2) or [s~P]-orthophosphate  (lanes 3 and 
4). Immunoprecipitation analysis (as in Fig. 1) included normal goat serum (lane 3), goat anti- 
AKR MuLV (lanes 1 and  4), and  goat  anti-BV2 (lane 2).  (B) Pulse-chase analysis of p36 
expression in BI0.G-V. Cells were pulsed for 20 min with [3H]leucine  and then washed and 
incubated in complete medium. At indicated times of chase, an aliquot of cell suspension was 
removed, washed with cold PBS, extracted,  and  immunoprecipitated with goat anti-AKR 
MuLV, then analyzed by gel electrophoresis and fluorography. (C) Pulse-chase  analysis as in 
(B) using AQR-V cells at indicated times of chase immunoprecipitated with anti-AKR MuLV. 
were  obtained  with  anti-gag  sera.  Analysis  of  32P-labeled  AQR-V  cells  also 
revealed a  phosphorylated p36 band which co-migrated with 3H-labeled p36 on 
gel electrophoresis (data not shown). 
The in vivo 32P-labeled p36 was subjected to acid hydrolysis and two-dimen- 
sional  analysis  for  identification  of phosphorylated  amino  acids  (23).  By  this 
method, p36 was found to contain abundant phosphoserine, but no phosphoty- 
rosine or phosphothreonine were detected (data not shown). 
We also tested anti-gag protein immune precipitates of AQR-V and B10.G-V 
extracts for in vitro phosphorylating activity using [7-32P]-ATP by the protocol 
of Witte  et al.  (24).  Neither p36  nor other proteins precipitated  by anti-viral 
antisera became detectably phosphorylated in these assays (data not shown). 
p36 Is Associated with RadLV-induced  Transformation.  Several other  thymic 280  IDENTIFICATION OF A GAG-RELATED PHOSPHOPROTEIN 
FIGURE 4.  Comparison of [SH]leucine containing tryptic peptides resolved by two-dimen- 
sional mapping as described in Materials and Methods. Proteins were of 4-h labeled AQR-V 
cells (A) p36 (B) p30 (C) Pr65  ~  (D) A schematic diagram of a composite  of tryptic peptides 
from all three proteins, proposing; O, peptides shared by p30 and Pr65  ~  and O, peptides 
unique to P36 within the pattern. 
lymphoma cell lines were assayed for production  of p36,  including other than 
AQR-V RadLV-induced lines and lines adapted from thymomas caused in vivo 
by x-irradiation.  These data are shown in  Figs.  2  and  5(A) and summarized  in 
Table I. Although the amounts of p36 synthesized in pulse-labeling experiments 
varied among  the  RadLV-induced cell lines,  all  expressed detectable levels of 
p36.  None  of  the  radiation-induced  lymphoma  cell  line  extracts  contained 
detectable p36.  Notably, two of these lines, AQR-X1 and B6.X1, release infec- 
tious virus into the culture medium and express readily precipitable gag proteins 
(Fig. 5A, lane 5), yet do not produce p36.  P36 was also detected in extracts of 
primary  RadLV-induced  tumors  but  was  not  detected  in  extracts  of normal 
thymocytes of  C57BL mice (Fig. 5B, lanes 1-3). In addition, primary spontaneous 
thymomas of AKR/J mice, which do express the MuLV structural proteins and 
their  precursors,  do  not  express  p36  (Fig.  5B,  lane  4).  These  findings  are 
consistent with a role for p36 in RadLV leukemogenesis. BACH AND  MERUELO  281 
FIGURE .~.  p36 expression in (A) lymphoma cell lines and (B) in vivo-derived  thymic cells of 
varied etiology. (A) Goat anti-BV2 immtinoprecipitates of [~H]ieucine-labeled cell extracts: 
RadLV induced cell lines B6-V1 (1) and B10.S-V (2); x-irradiation induced cell lines RL-12 
O), BI0.G-X (4), and  AQR-X (5). (B) Goat-anti-BY2 immunoprecipitates of [nH]leucine- 
labeled normal B10.Q mouse  thymocyes  (1), and thymomas  from RadLV-inoculated  B10.AQR 
(2) and  BI0.Q  (3) mice, and a  thymoma spontaneously arising in an AKR]J mouse (4). 
Comparable amounts of TCA-precipitable radioactivity were used for each analysis. 
Discussion 
Our  analysis  of  the  polypeptides  precipitated  by  anti-viral  antisera  from 
RadLV-induced lymphoma cell lines has resulted in the identification of a novel 
36,000-molecular weight gag-associated protein, p36.  This polypeptide appears 
to be specific to in vivo transformation  by RadLV (and persists in in vitro grown 
RadLV-transformed  cell  lines),  as  it  is  present  in  several  thymoma  cell  lines 
induced in vivo by RadLV, but not in normal thymocytes, Sc-1 mouse fibroblasts, 
nor any cell line adapted from thymic tumors induced in vivo by X-irradiation. 
Several  lines  of evidence  suggest  that  p36  is  not  merely  a  gag  processing 
intermediate, such as Pr40  s~g. The kinetics of appearance and loss of p36 during 
pulse-chase experiments show that p36 is synthesized rapidly, without the consid- 
erable lag seen for p30. The production of p36 in the B10.G-V lymphoma lines, 
which  does  not  release  infectious  virus  into  the  culture  medium  and  lacks 
detectable  synthesis  of  Pr65 g~g  and  p30  over  the  entire  pulse-chase  period, 
supports  the  independence  of  p36  expression  from  normal  gag  processing. 
Furthermore,  the finding that p36 is preciptiated by anti-pl2  and anti-pl 5 and 
is phosphorylated in vivo are unusual for a gag intermediate of its size. Of viral 
molecules in  this  molecular weight range,  Pr40  g~g contains only p30  linked  to 
pl0 and does not incorporate radiolabeled phosphate (26).  Finally, the compar- 
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that  Pr65 g~g and p30  share several peptides as  expected but  p36  has  unique 
peptides. 
The failure of p36 to appear in AQR-V supernatants containing virus-infected 
cells with a known capacity to replicate a wide range of murine leukemia viruses 
strongly suggests that it is either encoded for by a defective virus or it is a cellular 
protein(s)  expressed only in  cells transformed by  RadLV.  The  fact that  it  is 
precipitated by viral anti-gag antibodies, suggests it might be encoded in a gag- 
cell gene fusion and be the product of a  defective component of RadLV that 
participates in lymphomagenesis. This situation would be analogous to the acute 
murine leukemia viruses AbLV (7,  31) and spleen focus-forming virus (SFFV) 
(32,  33).  The  expression  of p36  in  the  absence  of helper virus  gag  protein 
synthesis in the B10.G-V line could then be attributed to loss of the nonessential 
helper function while acquiring the capability of p36  synthesis that would be 
required for maintenance of the transformed leukemic phenotype. 
Consistent with this hypothesis are the additional features of p36 that resemble 
those  of transformation-specific proteins  of certain  acute  defective leukemia 
viruses, such as AbLV p120  (7): p36  is precipitable with anti-gag but not anti- 
env sera, and is found phosphorylated in vivo. P36 is not expressed by fibroblasts 
or lymphoid cells infected in vitro with viruses passaged from AQR-V superna- 
tant. Similarly, as for AbLV, p120 is not expressed by L691-6 cells infected in 
vitro with AbLV and Mo-MuLV (7).  Like AbLV p120 (7) and SFFV gp55 (33, 
34), p36  is not found incorporated in significant amounts into mature virions. 
Unlike AbLV p120, p36 was not found to contain phosphotyrosine and did not 
show any detectable ATP-specific protein kinase activity. However, these findings 
were not  unexpected, as the phosphorylation of tyrosine has not been found 
associated with tumorigenesis by MuLV; additionally several other defined onc 
gene products, including those of the murine sarcoma viruses (35,  36), do not 
possess any ATP-specific protein kinase function. 
It is possible that p36 may correspond to the 36,000-molecular weight in vitro 
translation product of the defective 5.6-kb RNA of leukemogenic RadLV/VL3 
described by Manteuil-Brutlag et al. (10), which has never been demonstrated in 
vivo  in  lymphoma  cells.  The  presence  of  the  5.6-kb  RNA  of  RadLV  was 
correlated in  their studies with  leukemogenic potential.  When isolated 5.6-kb 
RNA, which resembles other acute retroviruses in containing a centrally substi- 
tuted region, was used to  program a  reticulocyte lysate, proteins of 100,000, 
36,000,  and  30,000  molecular weight  were  translated  (10).  These  could  be 
precipitated by antibody against pl 2 and pl 5. In our analysis of RadLV-induced 
lymphoma lines, we have failed to identify a  100,000 molecular weight polypep- 
tide with these characteristics. The products identified by Manteuil-Brutlag et 
al. (10) were not precipitated with anti-p30 antisera, while p36 is readily detected 
in anti-p30  immune precipitates of cellular extracts. This may indicate lack of 
identity of these proteins,  or reflect heterogeneity of anti-viral  heteroantisera 
and contaminating reactivities. The relatedness of these proteins remains to be 
clarified by further investigation. 
As an alternative to expression of p36 from defective RadLV RNA molecules, 
p36 might be induced from the host cell genome by transformation with RadLV. 
In this case, p36 would resemble the 53,000-molecular weight protein induced BACH AND  MERUELO  283 
in a number of cell types of different modes of transformation  (37), or the c-myc 
gene  product,  whose expression  is  thought  to  be  increased  in  ALV-induced 
lymphomas  of chickens  by nearby  integration  of the  ALV provirus  promoter 
region (38). That RadLV may act in such a fashion is supported by the suggestion 
that  RadLV  integrates  into  a  preferred  site  in  the  host  genome  (39).  The 
consistent size of p36  among independently  derived RadLV lymphomas,  how- 
ever,  would suggest a  mechanism  of induction  differing  from  ALV promoter 
insertion,  which  can  occur at  variable distances  from  the  c-myc gene.  Current 
work in our laboratory should help distinguish between these possibilities. 
Summary 
Radiation leukemia virus (RadLV) causes thymic iymphoma in 90% of suscep- 
tible mice after a  latent period of several months. The virally encoded polypep- 
tides produced by RadLV-induced  lymphoma cells were analyzed by immuno- 
precipitation and NaDodSO4/polyacrylamide gel electrophoresis. Along with the 
expected precursor and mature forms of gag and env gene products, a polypep- 
tide of 36,000  molecular weight (p36) was precipitated by anti-gag antisera.  It 
was not precipitable by normal sera or anti-env antibodies. Like the gag-associated 
fusion proteins of some acute leukemia viruses, p36  was found to be phospho- 
rylated in vivo, although it lacked detectable ATP-specific protein kinase activity 
in vitro. By kinetics during pulse-chase labeling experiments and by comparison 
of two-dimensional  tryptic peptide maps,  this protein  is not an intermediate  in 
gag precursor processing. One lymphoma cell line is described that resembles a 
nonproducer RadLV-transformant,  synthesizing relatively large amounts of p36 
in the absence of Pr66 gag or p30 production. Several RadLV-induced lymphoma 
cell lines also produce p36, while it was not detectable in the radiation-induced 
lines tested. In addition, p36 was not produced by mouse or mink fibroblasts or 
cultured  thymocyte  cell  lines  infected  with  virus  passaged  from  the  RadLV- 
induced  lymphomas.  We conclude that p36  may represent a  previously unrec- 
ognized transformation-related protein induced directly or indirectly by infection 
with RadLV. 
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